Agile Therapeutics, Inc. (AGRX): Price and Financial Metrics


Agile Therapeutics, Inc. (AGRX): $1.54

-0.01 (-0.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AGRX POWR Grades


  • Value is the dimension where AGRX ranks best; there it ranks ahead of 39.36% of US stocks.
  • The strongest trend for AGRX is in Quality, which has been heading down over the past 31 weeks.
  • AGRX ranks lowest in Momentum; there it ranks in the 5th percentile.

AGRX Stock Summary

  • Agile Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 9.71% of US listed stocks.
  • With a price/sales ratio of 156.12, Agile Therapeutics Inc has a higher such ratio than 97.22% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, Agile Therapeutics Inc is reporting a growth rate of 168.25%; that's higher than 89.63% of US stocks.
  • Stocks that are quantitatively similar to AGRX, based on their financial statements, market capitalization, and price volatility, are ARTW, CEMI, RWLK, KERN, and IBIO.
  • Visit AGRX's SEC page to see the company's official filings. To visit the company's web site, go to www.agiletherapeutics.com.

AGRX Price Target

For more insight on analysts targets of AGRX, see our AGRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.25 Average Broker Recommendation 1.3 (Strong Buy)

AGRX Stock Price Chart Interactive Chart >

Price chart for AGRX

AGRX Price/Volume Stats

Current price $1.54 52-week high $3.89
Prev. close $1.55 52-week low $1.28
Day low $1.54 Volume 441,300
Day high $1.58 Avg. volume 1,336,470
50-day MA $1.71 Dividend yield N/A
200-day MA $2.60 Market Cap 135.93M

Agile Therapeutics, Inc. (AGRX) Company Bio


Agile Therapeutics, Inc. focuses on the development and commercialization of prescription contraceptive products for women. The company was founded in 1997 and is based in Princeton, New Jersey.


AGRX Latest News Stream


Event/Time News Detail
Loading, please wait...

AGRX Latest Social Stream


Loading social stream, please wait...

View Full AGRX Social Stream

Latest AGRX News From Around the Web

Below are the latest news stories about Agile Therapeutics Inc that investors may wish to consider to help them evaluate AGRX as an investment opportunity.

Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference

PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the company will be participating virtually in the William Blair 41st Annual Growth Stock Conference. Chairman and Chief Executive Officer Al Altomari is scheduled to participate in a fireside chat on Tuesday, June 1, 2021 at 10:20 a.m. Eastern Time. The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Agile Therapeutics website or by clicking here: https://wsw.com/webcast/blair58/agrx/1940510. The webcast will be archived on the Agile Therapeutics website for 30 days following the event. About Agile Therapeutics, Inc. Agile Therapeutics is a forward-looking women's healthcare company dedicated to fu...

Yahoo | May 26, 2021

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ: HOOK ) Novo Nordisk A/S (NYSE: NVO ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 11) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 4D pharma plc (NASDAQ: LBPS ) Acutus Medical, Inc. (NASDAQ: AFIB ) Adagene Inc. (NASDAQ: ADAG ) Adaptive Biotechnologies Corporation (NASDAQ: ADPT ) ADC Therapeutics SA (NYSE: ADCT ) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akouos, Inc. (NASDAQ: AKUS ) (reacted to presentation of non-clinical data on gene therapy candidates at the American Society of Gene and Cell Therapy meeting) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Ap...

Benzinga | May 12, 2021

Agile Therapeutics to Participate in Virtual Fireside Chat as Part of the 2021 RBC Capital Markets Global Healthcare Conference

PRINCETON, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat as part of the 2021 RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 1:20 p.m. ET. The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/, or by clicking here: https://event.on24.com/wcc/r/3173531/F391B23E756682EFEFE4952267784F45 The webcast will be archived on the Agile Therapeutics website for 30 days following the event. About Agile Therapeutics, Inc. Agile Therapeutics is a forward-look...

Yahoo | May 12, 2021

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV ) - Its Allergan subsidiary announced a deal to buy Soliton, Inc. (NASDAQ: SOLY ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Novo Nordisk A/S (NYSE: NVO ) Quest Diagnostics Incorporated (NYSE: DGX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 10) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 4D pharma plc (NASDAQ: LBPS ) Accelerate Diagnostics, Inc. (NASDAQ: AXDX ) Acutus Medical, Inc. (NASDAQ: AFIB ) Adagene Inc. (NASDAQ: ADAG ) Adaptive Biotechnologies Corporation (NASDAQ: ADPT ) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Aquestive Therapeutics, Inc. (NASDAQ: A...

Benzinga | May 11, 2021

Agile Therapeutics (AGRX) Q1 2021 Earnings Call Transcript

AGRX earnings call for the period ending March 31, 2021.

Yahoo | May 5, 2021

Read More 'AGRX' Stories Here

AGRX Price Returns

1-mo -4.35%
3-mo -25.60%
6-mo -46.90%
1-year -44.80%
3-year 170.18%
5-year -79.55%
YTD -46.34%
2020 14.80%
2019 331.03%
2018 -78.44%
2017 -52.81%
2016 -41.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.873 seconds.